NHS

LloydsPharmacy and London North West University Healthcare NHS Trust are running mobile gastroenterology units. 

It has become increasingly important to harness emerging technologies for the early detection of serious conditions.

The CMA alleges Aspen agreed to pay Amilco and Tiofarma to stay out of the UK market for Addison’s Disease medicine.

The campaign will consist of TV, radio and digital advertising supported by search and partnership activity.

The Department of Health and Social Care yesterday released the final list of drug price concessions for September.

Pharmacists have been warned about “a lot of non-compliant labelling out there” on CBD products.

Most local pharmaceutical committees have made a start on their primary care network journey says Michael Lennox. 

The Department of Health and Social Care has announced the final list of drug price concessions for September.

The prescription penalty charge system often wrongly presumes guilt and needs clarity, says a House of Commons report.

This month's latest clinical news.

Prescriptions for gabapentin, pregabalin, and oxycodone rose consistently each year between 2013 and 2018.

NPA vice-chair Andrew Lane warns the five-year community pharmacy settlement may fail to prevent the closure of pharmacies.

Pharmacies will need to do 1,871 CPCS interventions to reclaim a £26,200 shortfall in revenue, warns Hemant Patel.

The finalists for this year’s Independent Pharmacy Awards at the House of Commons have been announced.

Revalidation and IT are areas that, on reflection, require our correspondent’s attention...    

The PDA asks Sajid Javid for funding to allow pharmacists to have more detailed talks with patients about their medicines.

Pharmacist Support chief executive Danielle Hunt says the charity needs funding to survive. 

LloydsPharmacy’s parent company singles out NHS “underfunding” and falling prescription numbers as challenges.

Pharmacists need leadership skills training and the RPS needs to learn how to lead, says Hemant Patel.

The PSNC's Alastair Buxton said the level of community pharmacy funding for primary care networks has not been finalised.